Research Article
Biomarkers of Hemodynamic Stress and Aortic Stiffness after STEMI: A Cross-Sectional Analysis
| | Study population () | | | Mean/median/number |
| | Age, years | 59 ± 10 | | Female, (%) | 7 (13) | | Body mass index, kg/m2 | 27 ± 3 | | Family history for AMI, (%) | 12 (22) | | Smoking status, (%) | 25 (46) | | Hypertension, (%) | 44 (81) | | Hyperlipidemia, (%) | 36 (67) | | Diabetes mellitus, (%) | 5 (9) | | Pain-to-balloon time, min | 261 (129–759) | | Anterior STEMI, (%) | 17 (32) | | Culprit lesion, (%) | | | LAD | 16 (30) | | LCX | 10 (18) | | RCA | 28 (52) | | Vessel disease, (%) | | | 1 | 24 (44) | | 2 | 23 (43) | | 3 | 7 (13) | | Creatinine, mg/dL | 0.98 ± 0.15 | | eGFR, mL/min/1.73 m2 | 83 ± 15 | | NT-proBNP, ng/L | 219 (119–412) | | MR-proANP, pmol/L | 88 (68–128) | | MR-proADM, nmol/L | 0.7 ± 0.2 | | PWV, m/sec | 7.2 ± 2.0 |
|
|
AMI = acute myocardial infarction; STEMI = ST-segment elevation myocardial infarction; LAD = left anterior descending artery; LCX = left circumflex artery; RCA = right coronary artery; eGFR = estimated glomerular filtration rate; NT-proBNP = N-terminal pro–B-type natriuretic peptide; MR-proANP = mid-regional pro–A-type natriuretic peptide; MR-proADM = mid-regional proadrenomedullin; PWV = pulse wave velocity.
|
